LKB1 is a serine/threonine kinase that is highly conserved throughout evolution. Its activity is allosterically controlled by interactions with the scaffold protein MO25 and the pseudo kinase STRAD (Rajakulendran and Sicheri, 2010) . LKB1 acts as a master kinase that phosphorylates 14 kinases within a shared consensus motif (Hardie and Alessi, 2013) . Germline mutations in the LKB1 gene cause PeutzJeghers syndrome, which is associated with increased cancer risk (Hemminki et al., 1998; Jenne et al., 1998) , and inactivating somatic LKB1 mutations are found in several sporadic cancers, including melanoma (Guldberg et al., 1999; Rowan et al., 1999) . Moreover, evidence from mouse models points to a prominent role for LKB1 as a suppres sor of metastasis in lung cancer and melanoma (Ji et al., 2007; Liu et al., 2012) .
The contribution of the different LKB1 substrates to tumor suppression is poorly understood, with the exception of AMP activated protein kinase (AMPK). AMPK is activated in an LKB1dependent manner in metabolically stressed cells, and, in turn, phosphorylates key metabolic enzymes and transcrip tion factors, causing a shift from anabolic (ATPconsuming) to catabolic (ATPproducing) metabolism (Hardie and Alessi, 2013 ; Fig. 1 ). This represents a crucial cellular response to metabolic stress that arrests cell proliferation and biosynthesis of macro molecules to restore energy homeostasis. As part of this response, AMPK inhibits the nutrient/energy/redox sensor mTORC1, which controls protein synthesis. Unrestrained mTORC1 activ ity in the absence of LKB1AMPK activity leads to continued Gradients of soluble attractants as well as extracellular matrix (ECM) proteins serve as cues for directional cell movement. Such "chemotaxis" and "haptotaxis" steers migration of cells during embryonic development, wound healing, and immune responses. In this issue, Chan et al. (2014 . J. Cell Biol. http://dx.doi.org/10.1083 show that the tumor suppressor LKB1 controls haptotaxis through the microtubule affinity-regulating kinase (MARK) family, one of the many substrates of the LKB1 master kinase. In the absence of this pathway, melanoma cells migrate irrespective of ECM gradients, which may explain the increased metastatic spread observed in LKB1-deficient tumors.
Correspondence to Erik H.J. Danen: e.danen@lacdr.leidenuniv.nl translation of HIF1, a transcription factor that helps tumor cells to switch from mitochondrial oxidative metabolism to aerobic glycolysis, a process referred to as "the Warburg ef fect" (Vander Heiden et al., 2009 ). Thus, loss of LKB1AMPK signaling allows cancer cells to disregard metabolic stress and continue proliferating.
In addition to its role in metabolism, LKB1 controls cell division orientation and polarity (Baas et al., 2004; Mirouse and Billaud, 2011) . Several LKB1 substrates have been implicated in this process, but activation of AMPK may be the predomi nant pathway (Zhang et al., 2006; Lee et al., 2007; Zheng and Cantley, 2007) . AMPK directly or indirectly phosphorylates the myosin II regulatory light chain, thereby activating the myosin II motor protein that drives actomyosin contractility, which is es sential for cell polarity (Lee et al., 2007) . Consequently, loss of LKB1AMPK activity not only allows cancer cells to rewire metabolic signaling networks but also causes loss of epithelial polarity, which contributes to tumorigenesis (MartinBelmonte and PerezMoreno, 2012) .
Attenuated AMPKmediated signaling could also be in volved in the increased metastatic potential of LKB1deficient cancers. Loss of polarity not only contributes to tumorigenesis but also equips cancer cells with a morphology fit for invasion of surrounding tissues and dissemination to distant organs. The in creased abundance of HIF1, in addition to metabolic rewiring, transcriptionally activates programs involved in epithelialto mesenchymal transition (EMT), matrix remodeling, and growth factor signaling that promote cell migration, local invasion, and dissemination (Lu and Kang, 2010) . However, AMPK phos phorylates the microtubule plusendtracking protein CLIP170 to support microtubule dynamics and cell migration (Nakano et al., 2010) . It is not known to what extent changes in these LKB1AMPK-regulated processes contribute to metastasis of LKB1deficient tumors. In melanoma and lung cancer where genetic mouse studies implicate LKB1 in metastasis suppres sion, the relevant LKB1 substrate is unidentified, but in both cases expansion of a CD24 + highly metastatic cell population is observed (Ji et al., 2007; Liu et al., 2012) .
The work by Chan et al. adds a new function to LKB1 that may underlie its role as a metastasis suppressor. In several melanoma cell models the authors test how depletion or recon stitution of LKB1 affects cell migration. The presence of LKB1 limits cell migration on 2D and in 3D ECM substrates. Cells lacking LKB1 do not pause at ECM boundaries and migrate ran domly with respect to 2D or 3D ECM gradients, whereas chemo taxis is fully intact. Notably, LKB1 does not regulate signaling by the integrin family of ECM receptors, secretion of ECM degrading proteases, or formation of proinvasive cell substratum contacts called invadopodia. The authors show that haptotaxis requires membranetargeted, kinaseactive LKB1. They use RNA interference and pharmacological inhibitors to exclude involve ment of AMPK and several other LKB1 substrates expressed in the melanoma cells. Instead, they establish that the microtubule affinityregulating kinases (MARKs) are essential mediators of LKB1dependent haptotaxis. MARKs are known to phosphorylate microtubuleassociated proteins (MAPs), thereby destabilizing microtubules (Illenberger et al., 1996) . However, strikingly, the LKB1MARK-mediated haptotaxis identified by Chan et al. (2014) does not depend on MAP phosphorylation, nor does it require intact microtubules.
This work adds a new branch to the LKB1 signaling net work that may be specifically important for its role as a metastasis suppressor. Future studies will have to unravel how LKB1 MARK signaling controls haptotaxis, if not through MAP mediated control of microtubule dynamics. What is the relevant MARK substrate for LKB1controlled haptotaxis? Moreover, as is the case for most LKB1controlled processes, it is unknown to what extent these findings are context dependent. Is the role for LKB1 in haptotaxis specific for melanoma cells? How is it affected by the repertoire of mutated oncogenes and tumor suppressors in a given cancer? And, perhaps most urgent, is this pathway really responsible for the strong metastatic potential of LKB1deficient melanomas? The authors provide evidence that MARKs limit melanoma cell invasion in 3D ECM sub strates, but the question of whether LKB1MARK-mediated haptotaxis represents a metastasissuppressing process remains to be answered. 
